Related Experiment Video
Updated: Dec 6, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Impact of atrial fibrillation on outcomes following MitraClip: A contemporary population-based analysis
Anas M Saad1, Nicholas Kassis2, Mohamed M Gad2
1Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Objectives:
Despite the rising use of MC, the impact of preexisting AF, a common comorbidity, on short-term postprocedural outcomes is poorly defined. We sought to assess outcomes between patients with and without atrial fibrillation (AF) who underwent percutaneous mitral valve repair with MitraClip (MC).
Methods:
In this retrospective cohort study, the Nationwide Readmissions Database was queried for patients who underwent MC between 2014-2017. Groups were stratified based on the presence of AF. Multivariable logistic regression analyses were performed to identify the association between AF and in-hospital stroke and mortality.
Results:
Of the 15,570 patients who underwent MC, 7,740 (49.7%) had AF. AF patients were older (82 vs. 79 years, p < .001) and more comorbid. Patients with AF relative to without AF demonstrated increased rates of in-hospital ischemic (1.3% vs .0.7%, p < .001) and hemorrhagic stroke (0.3% vs. 0.1%, p = .007), longer duration of hospitalization (median 3 vs. 2 days, p < .001), and similar in-hospital mortality (2.8% vs. 2.6%, p = .52). After adjusting for comorbidities, age, sex, hospital procedural volume, and CHA2DS2-VASc, the presence of AF was associated with higher in-hospital stroke (OR = 2.096, 95%CI[1.503-2.921], p < .001) but not in-hospital mortality (OR = 1.012, 95%CI[0.828-1.238], p = .904). AF patients were more likely to be readmitted (16.8% vs.14.1%, p < .001) and die (1.5% vs. 0.9%, p = .005) within 30 days of discharge despite similar incidences of stroke (0.7% vs. 0.6%, p = .53).
Conclusions:
The increased risk of in-hospital stroke, 30-day mortality, and longer hospitalization suggest the need for increased preprocedural optimization by means of stroke prevention strategies in those with AF undergoing MC.
Insights
Patients with atrial fibrillation (AF) undergoing MitraClip (MC) repair face higher risks of stroke and 30-day mortality. Optimization of stroke prevention strategies is crucial for this patient group.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Medical Outcomes Research
Background:
- Atrial fibrillation (AF) is a common comorbidity in patients undergoing cardiac procedures.
- The impact of AF on short-term outcomes after percutaneous mitral valve repair with MitraClip (MC) is not well-defined.
Purpose of the Study:
- To assess and compare short-term postprocedural outcomes between patients with and without AF who underwent MC.
- To identify the association between AF and in-hospital stroke and mortality after MC.
Main Methods:
- Retrospective cohort study using the Nationwide Readmissions Database (2014-2017).
- Stratification of patients based on the presence of AF.
- Multivariable logistic regression analyses to determine the association between AF and in-hospital stroke/mortality.
Main Results:
- Nearly half (49.7%) of 15,570 MC patients had AF; these patients were older and more comorbid.
- AF patients had significantly higher rates of in-hospital ischemic and hemorrhagic stroke compared to non-AF patients.
- Adjusted analyses revealed AF was associated with increased in-hospital stroke (OR=2.096) but not in-hospital mortality. AF patients also experienced longer hospitalizations and higher 30-day readmission and mortality rates.
Conclusions:
- Patients with AF undergoing MC repair have an elevated risk of in-hospital stroke and 30-day mortality.
- These findings underscore the need for enhanced preprocedural optimization and stroke prevention strategies for AF patients undergoing MC.
- Further research into tailored management for AF patients undergoing MitraClip is warranted.
Related Concept Videos
Mitral Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Regurgitation I: Introduction
Mitral Stenosis I: Introduction

